Table 3.
Baseline
|
3 months
|
12 months
|
||||
---|---|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | |
Univariate | ||||||
Sodium | 1.13 (1.05–1.20) | 0.001* | 1.09 (1.01–1.17) | 0.022* | 1.15 (1.05–1.27) | 0.003* |
Chloride | 1.27 (1.18–1.35) | <0.001* | 1.25 (1.16–1.34) | <0.001* | 1.34 (1.22–1.46) | <0.001* |
Bicarbonate | 1.05 (0.98–1.13) | 0.152 | 1.01 (0.94–1.09) | 0.729 | 1.03 (0.93–1.13) | 0.611 |
Multivariable | ||||||
Sodium | 0.97 (0.89–1.06) | 0.521 | 0.89 (0.81–0.98) | 0.015* | 0.90 (0.80–1.02) | 0.091 |
Chloride | 1.30 (1.18–1.42) | <0.001* | 1.38 (1.25–1.52) | <0.001* | 1.49 (1.31–1.69) | <0.001* |
Bicarbonate | 1.03 (0.96–1.11) | 0.430 | 1.11 (1.02–1.20) | 0.022* | 1.13 (1.01–1.25) | 0.031* |
Multivariable with adjustment for baseline characteristics | ||||||
Sodium | 0.93 (0.86–1.02) | 0.147 | 0.91 (0.83–1.01) | 0.063 | 0.95 (0.84–1.07) | 0.392 |
Chloride | 1.19 (1.08–1.31) | <0.001* | 1.24 (1.12–1.38) | <0.001* | 1.34 (1.17–1.53) | <0.001* |
Bicarbonate | 1.02 (0.95–1.11) | 0.547 | 1.09 (1.00–1.19) | 0.063 | 1.08 (0.97–1.21) | 0.148 |
Baseline characteristics adjusted for include: medications (bucindolol, digoxin, loop diuretic dose, ACE inhibitor, and vasodilators), coronary artery disease, diabetes, hypertension, age, gender, ejection fraction, systolic blood pressure, New York Heart Association class, haemoglobin level, estimated glomerular filtration rate, blood urea nitrogen, and the blood urea nitrogen to creatinine ratio.
CI, confidence interval; HR, hazard ratio.
The HR is expressed per standard deviation decrease for chloride and sodium and per standard deviation increase for bicarbonate.